Cordio Mecidal has completed a successful strategic Series C funding round raising a total of $18M

The investment will support clinical studies, partnerships, operations, and R&D

Cordio’s proprietary HearO® mobile app and medical analysis algorithms detect fluid accumulations associated with a deterioration in the condition of patients suffering from Congestive Heart Failure. By detecting early warning signs of a decline in the health of CHF patients, the platform can alert a healthcare professional in real-time. CHF affects nearly 6 Million Americans and many more across the globe.